157 related articles for article (PubMed ID: 25385157)
1. Clinical features of 280 hospitalized patients with lymphangioleiomyomatosis in Japan.
Hasegawa W; Yamauchi Y; Yasunaga H; Sunohara M; Jo T; Matsui H; Fushimi K; Takami K; Nagase T
Respirology; 2015 Jan; 20(1):160-5. PubMed ID: 25385157
[TBL] [Abstract][Full Text] [Related]
2. Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan.
Oishi H; Watanabe T; Matsuda Y; Noda M; Ejima Y; Saiki Y; Seyama K; Kondo T; Okada Y
Surg Today; 2018 Oct; 48(10):944-950. PubMed ID: 29808303
[TBL] [Abstract][Full Text] [Related]
3. Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center.
Kurosaki T; Otani S; Miyoshi K; Okazaki M; Sugimoto S; Suno M; Yamane M; Kobayashi M; Oto T; Toyooka S
Clin Respir J; 2020 Feb; 14(2):116-123. PubMed ID: 31729820
[TBL] [Abstract][Full Text] [Related]
4. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.
Almoosa KF; Ryu JH; Mendez J; Huggins JT; Young LR; Sullivan EJ; Maurer J; McCormack FX; Sahn SA
Chest; 2006 May; 129(5):1274-81. PubMed ID: 16685019
[TBL] [Abstract][Full Text] [Related]
5. Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease.
Collins J; Müller NL; Kazerooni EA; McAdams HP; Leung AN; Love RB
Radiology; 1999 Feb; 210(2):325-32. PubMed ID: 10207410
[TBL] [Abstract][Full Text] [Related]
6. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
[TBL] [Abstract][Full Text] [Related]
7. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
8. Lung Transplantation for Lymphangioleiomyomatosis in Japan.
Ando K; Okada Y; Akiba M; Kondo T; Kawamura T; Okumura M; Chen F; Date H; Shiraishi T; Iwasaki A; Yamasaki N; Nagayasu T; Chida M; Inoue Y; Hirai T; Seyama K; Mishima M;
PLoS One; 2016; 11(1):e0146749. PubMed ID: 26771878
[TBL] [Abstract][Full Text] [Related]
9. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish registry.
Antón E; Casanova A; Xaubet A; Román A; Villena V; Montero MC; Molina-Molina M; Pérez-Sánchez E; Sueiro A; Morell F; Girón RM; Ancochea J
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):85-91. PubMed ID: 20560288
[TBL] [Abstract][Full Text] [Related]
10. Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.
Maurer JR; Ryu J; Beck G; Moss J; Lee JC; Finlay G; Brown K; Chapman J; McMahan J; Olson E; Ruoss S; Sherer S;
J Heart Lung Transplant; 2007 Dec; 26(12):1293-9. PubMed ID: 18096481
[TBL] [Abstract][Full Text] [Related]
11. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.
Kpodonu J; Massad MG; Chaer RA; Caines A; Evans A; Snow NJ; Geha AS
J Heart Lung Transplant; 2005 Sep; 24(9):1247-53. PubMed ID: 16143241
[TBL] [Abstract][Full Text] [Related]
12. Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study.
Sakurai T; Kanou T; Funaki S; Fukui E; Kimura T; Ose N; Inoue Y; Shintani Y
Respir Investig; 2024 Jul; 62(4):657-662. PubMed ID: 38761480
[TBL] [Abstract][Full Text] [Related]
13. Lung transplantation for lymphangioleiomyomatosis: the French experience.
Reynaud-Gaubert M; Mornex JF; Mal H; Treilhaud M; Dromer C; Quétant S; Leroy-Ladurie F; Guillemain R; Philit F; Dauriat G; Grenet D; Stern M
Transplantation; 2008 Aug; 86(4):515-20. PubMed ID: 18724219
[TBL] [Abstract][Full Text] [Related]
14. Emerging clinical picture of lymphangioleiomyomatosis.
Cohen MM; Pollock-BarZiv S; Johnson SR
Thorax; 2005 Oct; 60(10):875-9. PubMed ID: 16055626
[TBL] [Abstract][Full Text] [Related]
15. Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization.
Kristof AS; Zhi Li P; Major P; Landry JS
Chest; 2015 Aug; 148(2):444-449. PubMed ID: 25789699
[TBL] [Abstract][Full Text] [Related]
16. Rare lung diseases I--Lymphangioleiomyomatosis.
Juvet SC; Hwang D; Downey GP
Can Respir J; 2006 Oct; 13(7):375-80. PubMed ID: 17036091
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis.
Salman J; Ius F; Sommer W; Siemeni T; Fleissner F; Alhadidi H; Kugler C; Avsar M; Haverich A; Warnecke G; Tudorache I; Kuhn C
Prog Transplant; 2019 Jun; 29(2):115-121. PubMed ID: 31084354
[TBL] [Abstract][Full Text] [Related]
18. Incidental lymphangioleiomyomatosis in the lymph nodes of gynecologic surgical specimens.
Kuno I; Yoshida H; Shimizu H; Uehara T; Uno M; Ishikawa M; Kato T
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():93-97. PubMed ID: 30336310
[TBL] [Abstract][Full Text] [Related]
19. Canadian respirologists' experience with lymphangioleiomyomatosis.
Pollock-BarZiv SM; Cohen MM; Maclean H; Downey GP
Can Respir J; 2002; 9(6):413-6. PubMed ID: 12522487
[TBL] [Abstract][Full Text] [Related]
20. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.
Oprescu N; McCormack FX; Byrnes S; Kinder BW
Lung; 2013 Feb; 191(1):35-42. PubMed ID: 23007140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
